SCHEMBL4896705

SCHEMBL4896705

[c]1c(ON2CCNC2)ccc2ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 3/20 0.35
HTR3B O95264 3/20 0.35
HTR3A P46098 3/20 0.35
HTR3D Q70Z44 3/20 0.35
HTR3C Q8WXA8 3/20 0.35
CYP1A2 P05177 2/20 0.35
HTR1A P08908 2/20 0.35
HTR7 P34969 2/20 0.35
HTR6 P50406 2/20 0.35
HSD17B10 Q99714 2/20 0.35
SLC6A4 P31645 2/20 0.35
KDM4E B2RXH2 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ADRB1 P08588 1/20 0.35
CYP3A4 P08684 1/20 0.35
HTR2C P28335 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
PMP22 Q01453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4721746 0.91 HTR3E (0.40) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL4896569 0.87 HTR3E (0.37) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL4723265 0.80 HPGD (0.33) CYP1A2CYP3A4HTTTDP1
SCHEMBL4723142 0.79 HTR3E (0.30) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL4720552 0.78 HPGD (0.33) CYP1A2CYP3A4HTTTDP1TSHR
SCHEMBL4721363 0.78 HTR3A (0.42) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL4721989 0.76 TP53 (0.34) KDM4EALDH1A1TDP1TSHRPKM
SCHEMBL4721002 0.76 AR (0.31)
SCHEMBL4720355 0.72 HTR3E (0.32) HTR3EHTR3BHTR3AHTR3DHTR3C
SCHEMBL4720688 0.71 HTR3A (0.42) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200475-A1 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors PFIZER INC. 2008-08-21 US disclosed
US-20080194590-A1 4-Piperazinylthieno [2,3-D] Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC 2008-08-14 US disclosed
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 HTR3E 124/4885HTR3B 79/4885HTR3A 115/4885
US-20080194590-A1 4-Piperazinylthieno [2,3-D] Pyrimidine Compounds as Platelet Aggregation Inhibitors PFKP, PF4, P2RY4 HTR3E 359/4885HTR3B 279/4885HTR3A 535/4885
US-20080200475-A1 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors PF4, TBXA2R, P2RY4 HTR3E 341/4885HTR3B 185/4885HTR3A 270/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.